Lauren G Poole, Zimu Wei, Anthony Schulte, Holly M Cline, Matthew P Bernard, John P Buchweitz, Mitchell R McGill, James P Luyendyk
{"title":"Kupffer cell expression of macrophage receptor with collagenous structure (MARCO) modulates macrophage gene induction and limits acute liver injury.","authors":"Lauren G Poole, Zimu Wei, Anthony Schulte, Holly M Cline, Matthew P Bernard, John P Buchweitz, Mitchell R McGill, James P Luyendyk","doi":"10.1093/toxsci/kfaf037","DOIUrl":null,"url":null,"abstract":"<p><p>Macrophages displaying a pro-repair and anti-inflammatory polarization have been implicated in resolution of acute liver injury. Macrophage receptor with collagenous structure (MARCO) expression marks tolerogenic hepatic macrophages and is expressed by pro-resolution macrophages in the injured liver. We tested the hypothesis that MARCO promotes repair of the acetaminophen (APAP)-injured liver. Robust and sustained induction of MARCO mRNA and protein expression was evident in livers of mice challenged with a hepatotoxic dose of APAP (ie, 300 mg/kg), whereas hepatic MARCO induction failed in mice with APAP-induced liver failure (ie, 600 mg/kg). Serum proteomics identified a significant increase in serum MARCO levels in surviving acute liver failure (ALF) patients, but not in ALF patients who died. MARCO expression was high in F480+ liver macrophages, and MARCO deficiency reduced macrophage expression of pro-resolution markers such as Gpnmb and Mertk during the repair phase (ie, 48 hours). The results suggested a delay in necrosis resolution along with a trend towards increased mortality in APAP-challenged MARCO-/- mice. Notably, a robust increase in peak hepatic injury (ie, 6-24 hours post-APAP challenge) was evident in MARCO-/- mice, which could not be ascribed to differences in NAPQI/APAP-adduct generation nor changes in hepatic neutrophil/macrophage numbers. Interestingly, a reduction in hepatic CD11c+ cells, shown previously to limit APAP-induced liver injury, was evident 24 hours after APAP challenge in MARCO-/- mice. The results indicate that MARCO deficiency worsens APAP-induced acute liver injury in mice and provide experimental and initial translational evidence linking MARCO induction to positive outcomes in acute liver injury.</p>","PeriodicalId":23178,"journal":{"name":"Toxicological Sciences","volume":" ","pages":""},"PeriodicalIF":3.4000,"publicationDate":"2025-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Toxicological Sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/toxsci/kfaf037","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"TOXICOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
巨噬细胞具有促进修复和抗炎的极化特性,这与急性肝损伤的缓解有关。具有胶原结构的巨噬细胞受体(MARCO)的表达标志着具有耐受性的肝巨噬细胞,并由损伤肝脏中的促修复巨噬细胞表达。我们测试了 MARCO 促进对乙酰氨基酚(APAP)损伤肝脏修复的假设。在受到肝毒性剂量 APAP(即 300 毫克/千克)挑战的小鼠肝脏中,MARCO mRNA 和蛋白质的表达明显受到了强有力的持续诱导,而在 APAP 诱导的肝衰竭(即 600 毫克/千克)小鼠中,肝脏 MARCO 诱导失败。血清蛋白质组学发现,存活的急性肝衰竭(ALF)患者血清中的 MARCO 含量显著增加,而死亡的 ALF 患者血清中的 MARCO 含量则没有增加。在F480+肝巨噬细胞中,MARCO的表达量很高,而在修复阶段(即48小时),MARCO的缺乏会降低巨噬细胞对Gpnmb和Mertk等促溶解标志物的表达。结果表明,APAP-Challenged MARCO-/-小鼠的坏死缓解延迟,死亡率呈上升趋势。值得注意的是,MARCO-/-小鼠的肝损伤峰值(即 APAP 挑战后 6-24 小时)明显增加,这不能归因于 NAPQI/APAP-加成物生成的差异或肝脏中性粒细胞/巨噬细胞数量的变化。有趣的是,在 MARCO-/- 小鼠挑战 APAP 24 小时后,肝脏 CD11c+ 细胞明显减少,而之前的研究表明,这种细胞可限制 APAP 诱导的肝损伤。这些结果表明,MARCO 缺乏会加重 APAP 诱导的小鼠急性肝损伤,并提供了实验和初步的转化证据,证明 MARCO 诱导与急性肝损伤的积极结果有关。
Kupffer cell expression of macrophage receptor with collagenous structure (MARCO) modulates macrophage gene induction and limits acute liver injury.
Macrophages displaying a pro-repair and anti-inflammatory polarization have been implicated in resolution of acute liver injury. Macrophage receptor with collagenous structure (MARCO) expression marks tolerogenic hepatic macrophages and is expressed by pro-resolution macrophages in the injured liver. We tested the hypothesis that MARCO promotes repair of the acetaminophen (APAP)-injured liver. Robust and sustained induction of MARCO mRNA and protein expression was evident in livers of mice challenged with a hepatotoxic dose of APAP (ie, 300 mg/kg), whereas hepatic MARCO induction failed in mice with APAP-induced liver failure (ie, 600 mg/kg). Serum proteomics identified a significant increase in serum MARCO levels in surviving acute liver failure (ALF) patients, but not in ALF patients who died. MARCO expression was high in F480+ liver macrophages, and MARCO deficiency reduced macrophage expression of pro-resolution markers such as Gpnmb and Mertk during the repair phase (ie, 48 hours). The results suggested a delay in necrosis resolution along with a trend towards increased mortality in APAP-challenged MARCO-/- mice. Notably, a robust increase in peak hepatic injury (ie, 6-24 hours post-APAP challenge) was evident in MARCO-/- mice, which could not be ascribed to differences in NAPQI/APAP-adduct generation nor changes in hepatic neutrophil/macrophage numbers. Interestingly, a reduction in hepatic CD11c+ cells, shown previously to limit APAP-induced liver injury, was evident 24 hours after APAP challenge in MARCO-/- mice. The results indicate that MARCO deficiency worsens APAP-induced acute liver injury in mice and provide experimental and initial translational evidence linking MARCO induction to positive outcomes in acute liver injury.
期刊介绍:
The mission of Toxicological Sciences, the official journal of the Society of Toxicology, is to publish a broad spectrum of impactful research in the field of toxicology.
The primary focus of Toxicological Sciences is on original research articles. The journal also provides expert insight via contemporary and systematic reviews, as well as forum articles and editorial content that addresses important topics in the field.
The scope of Toxicological Sciences is focused on a broad spectrum of impactful toxicological research that will advance the multidisciplinary field of toxicology ranging from basic research to model development and application, and decision making. Submissions will include diverse technologies and approaches including, but not limited to: bioinformatics and computational biology, biochemistry, exposure science, histopathology, mass spectrometry, molecular biology, population-based sciences, tissue and cell-based systems, and whole-animal studies. Integrative approaches that combine realistic exposure scenarios with impactful analyses that move the field forward are encouraged.